Record cross-border deals flipped loss-making Chinese biotechs to profit, but tightening Big Pharma budgets could slam the funding door shut.

First-day trading for the aerospace and AI company turned an unprecedented IPO into a $2tn-style market reckoning for public-market readiness.

Forced buyers and tracker funds could amplify buying pressure as SpaceX joins the Nasdaq index on a rule tweak.

The SPCX listing breaks records, but Japanese household investors quietly took a meaningful chunk of the biggest payday ever.

Elon Musk's rocket company prices its world-scale IPO at $135 per share, moving into public markets immediately.

A $30 billion implied arrangement reshapes who supplies AI muscle, and how tech boards think about capacity and concentration.